Skip to content

Volume 88 · 125

Public Law 93–281

To amend the Controlled Substances Act to provide for the registration of practitioners conducting narcotic treatment programs.

Approved May 14, 1974

Statutory text

An Act

To amend the Controlled Substances Act to provide for the registration of practitioners conducting narcotic treatment programs.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

That this Act may be cited as the “Narcotic Addict Treatment Act of 1974”.

Sec. 2.

Section 102 of the Controlled Substances Act (21 U.S.C. 802) is amended by adding the following after paragraph (26):

“(27)

The term ‘maintenance treatment’ means the dispensing, for a period in excess of twenty-one days, of a narcotic drug in the treatment of an individual for dependence upon heroin or other morphine-like drugs.

“(28)

The term ‘detoxification treatment’ means the dispensing, for a period not in excess of twenty-one days, of a narcotic drug in decreasing doses to an individual in order to alleviate adverse physiological or psychological effects incident to withdrawal from the continuous or sustained use of a narcotic drug and as a method of bringing the individual to a narcotic drug-free state within such period.”

Sec. 3.

Section 303 of the Controlled Substances Act (21 U.S.C. 823)

Practitioners, narcotic drug dispensation, annual registration.

is amended by adding the following after subsection (f):

“(g)

Practitioners who dispense narcotic drugs to individuals for maintenance treatment or detoxification treatment shall obtain annually a separate registration for that purpose. The Attorney General

Qualifications.

shall register an applicant to dispense narcotic drugs to individuals for maintenance treatment or detoxification treatment (or both)—

“(1)

if the applicant is a practitioner who is determined by the Secretary to be qualified (under standards established by the Secretary) to engage in the treatment with respect to which registration is sought;

“(2)

if the Attorney General determines that the applicant will comply with standards established by the Attorney General respecting (A) security of stocks of narcotic drugs for such treatment, and (B) the maintenance of records (in accordance with section 307) on such drugs; and

21 USC 827.

“(3)

if the Secretary determines that the applicant will comply with standards established by the Secretary (after consultation with the Attorney General) respecting the quantities of narcotic drugs which may be provided for unsupervised use by individuals in such treatment.”.

Sec. 4.

(a)

Section 304(a) of the Controlled Substances Act (21

Suspension or revocation.

U.S.C. 824(a)) is amended by adding after and below paragraph (3) the following: “A registration pursuant to section 303(g) to dispense

21 USC 823.

a narcotic drug for maintenance treatment or detoxification treatment may be suspended or revoked by the Attorney General upon a finding that the registrant has failed to comply with any standard referred to in section 303(g).”

(b)

Section 304(d) of such Act is amended (1) by inserting after the first sentence the following: “A failure to comply with a standard referred to in section 303(g) may be treated under this subsection as grounds for immediate suspension of a registration granted under such section.”; and (2) by striking out “Such suspension” and inserting in lieu thereof “A suspension under this subsection”.

Sec. 5.

Section 307(c) (1) (A) of the Controlled Substances Act (21 U.S.C. 827(c)(1)(A)) is amended to read as follows:

“(1)
(A)

with respect to any narcotic controlled substance in schedule II, III, IV, or V, to the prescribing or administering of such substance by a practitioner in the lawful course of his professional practice unless such substance was prescribed or administered in the course of maintenance treatment or detoxification treatment of an individual; or”.

Approved May 14, 1974.

Parsed from the official Statutes at Large USLM XML in 88.xml